We envision sortilins and HLA/MHC proteins as potential therapeutic targets in cancer, diabetes, and neurodegenerative diseases, by modulation of antigen processing and immune response mechanisms in these diseases. This evidence concerns the gene SORT1 and diabetes mellitus.